Because your results can’t wait

Brain Image Quantitative Analysis System

Brain Image Quantitative Analysis System

A simple path from data
to decision-making
Advances in non-invasive brain imaging technologies allow us to study the brain more extensively
than ever. Neuro I Brain Image Quantitative Analysis System gives you the ability to makeobjective measurements of morphological changes with amazing accuracy. Neuro I uses deeplearning technologies to automate labeling, quantification, and visualization of significantstructures in the brain from magnetic resonance (MR) images. With longitudinal tracking features,Neuro I allows for the simple, objective, and accurate assessment of even a subtle amount of brain
atrophy. Save time, reduce bias, and increase accuracy with Neuro I.

High-performance processing
for high-quality data
Efficient, accurate, and robust segmentation of cortical surfaces and subcortical structures are
powered by 3D Convolutional Neural Network (CNN) based deep learning algorithms. The
sophisticated, easy-to-use software to help clinicians make confident, data-driven decisions.

Clinically relevant data
Neuro I compares a patient’s data to a large-scale normative database to provide clinicallyrelevant information.
Longitudinal, multi-domain data of cognitively normal (CN) Koreans (n ≈ 2,000+)
Segmentation data verified manually to ensure accuracy
Data quality control confirmed by radiology experts

Longitudinal tracking

Easy-to-use, intuitive software
Neuro I is cloud-based and runs in a standard browser. Simply upload your images and
Neuro I will automatically process, analyze, and organize your data into a streamlined
report.
Measurements of cortical surface thickness, subcortical structure volumes, andstatistical comparisons with a normative database
Longitudinal tracking of morphological changes

MRI viewer

Security safeguarded
User access control
Encrypted data transfer and storage

Hankook Ilbo Digital Innovation Award
The Korean Federation of Science and Technology Societies’ Top 10 Science News

3D viewer

Automatically generated reports with
MRI quantification data
Upload DICOM MRI data to Neuro I for automatic analysis. The results aredisplayed in an intuitive, easy-to-use interface and reports are automaticallygenerated in PDF format for both physicians and patients. Data can also beexported as CSV files for further evaluation.

| Brain Analysis Report

IMT Hospital

Subject information
Basic patient identifying
information and generalfollow-up data

Overview
Morphometry results for thewhole brain, gray matter, whitematter, and lateral ventricles
Volume: The volume of thestructure in cm3% of ICV: The space the structure
occupies within the patient’s
head; the intracranial volume(ICV) is used to normalize
individual brain structure volumes
Normative percentile: How thestructure relates to healthy
individuals of the same age andsex

20031923180621160109151714 31020907080804

1731 14102230

01

2901

28

2115122928

27

26
1113

192336
16

1025

24

1806

02

07
04

2003

01

05

30

37

2239
33

25

2705

Analysis details
Schematic visualization of the brain
segmented into 80 regions ofinterest (ROI) with at-risk regions
highlighted(red: caution, yellow: attention)

3440

40

32

32

38

38

35

35

36

39

37

33
34

26
1224
1113

Z-scores for 80 ROI
Z-scores shown for ROI
calculated compared to alarge-scale normative
population

Age-matched ROI Charts
Data for ROI in relation tonormative reference charts
matched to age and sex
Cortical ROI: Cortical thickness
measurements and comparisons
Subcortical at-risk ROI: Subcorticalvolume measurements andcomparisons

COMING SOON

Clinical Decision Support System

NeuroAI is a clinical decision support system to help standardize the interpretation of neuroimaging data to predict, diagnose, and monitor
Alzheimer’s disease (AD). NeuroAI increases diagnostic accuracy and disease characterization by measuring cortical thickness as well as
subcortical volumes. A patient’s data is age-matched and compared to a longitudinal, multi-domain normative database of CN, MCI, and AD

Find out more at neurozen.aiThe Neuro I Brain Image Quantitative Analysis System is a Class II medical device approved by the South Korean Ministry of Foodand Drug Safety (MFDS) and registered with the Thai Food and Drug Administration (FDA). Neuro I is not Intended for the primaryinterpretation of digital MR images. Patient management decisions should not be made based solely on the results of Neuro Ianalysis. Neurozen Co. is not liable for the use or handling of the results or any consequential, special, indirect, or incidental damages.

ⓒ Neurozen vNI2011-01

Korean adults to support physicians in making meaningful clinical diagnoses for better disease treatment and management.